# A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005)

> **NCT06665230** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 12 (actual)

## Conditions studied

- Healthy
- Narcolepsy

## Interventions

- **DRUG:** MK-6552
- **DRUG:** Modafinil

## Key facts

- **NCT ID:** NCT06665230
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-09-20
- **Primary completion:** 2023-11-20
- **Final completion:** 2023-11-20
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2024-10-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06665230

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06665230, "A Clinical Study of MK-6552 and Modafinil in Healthy Men (MK-6552-005)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06665230. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*